References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Luetal(2008)VitaminD3analogueEB1089inhibitstheproliferationofhumanlaryngealsquamouscarcinomacellsviap57.Mol.CancerTher.71268PMID:18483314
Bhatiaetal(2009)EB1089inhibitstheparathyroidhormone-relatedprotein-enhancedbonemetastasisandxenograftgrowthofhumanprostatecancercells.Mol.CancerTher.81787PMID:19584236
ABDaimietal(1999)ReversalofhypercalcaemiawiththevitaminDanalogueEB1089inahumanmodelofsquamouscancer.CancerRes,593325PMID:
Ormerodetal(2008)ThecalcitriolanalogueEB1089impairsalveolarizationandinduceslocalizedregionsofincreasedfibroblastdensityinneonatalratlung.Exp.Lung.Rs.34155PMID:
Hoyer-Hansenetal(2005)VitaminDanalogEB1089triggersdramaticlysosomalchangesandBeclin1-mediatedautophagiccelldeath.CellDeathDiffer.121297PMID:15905882
Keywords:EB1089,supplier,EB1089,VDR,agonist,Vitamin,D,receptors,seocalcitol,VDR-like,Seocalcitol,Vitamin,D,Receptors,Autophagy,Vitamin,D,Receptors,TocrisBioscience